Palisade Bio Inc
NASDAQ:PALI

Watchlist Manager
Palisade Bio Inc Logo
Palisade Bio Inc
NASDAQ:PALI
Watchlist
Price: 2.2 USD 5.26% Market Closed
Market Cap: 327.8m USD

Intrinsic Value

PALI doesn't have a meaningful market cap.

The intrinsic value of one PALI stock under the Base Case scenario is 0.08 USD. Compared to the current market price of 2.2 USD, Palisade Bio Inc is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PALI Intrinsic Value
0.08 USD
Overvaluation 96%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Palisade Bio Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about PALI?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PALI valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Palisade Bio Inc.

Explain Valuation
Compare PALI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PALI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Palisade Bio Inc

Current Assets 10.5m
Cash & Short-Term Investments 9.8m
Receivables 24k
Other Current Assets 649k
Non-Current Assets 386k
PP&E 87k
Other Non-Current Assets 299k
Current Liabilities 3.2m
Accounts Payable 1.1m
Accrued Liabilities 2.1m
Other Current Liabilities 79k
Non-Current Liabilities 152k
Other Non-Current Liabilities 152k
Efficiency

Free Cash Flow Analysis
Palisade Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Palisade Bio Inc

Revenue
0 USD
Operating Expenses
-14.9m USD
Operating Income
-14.9m USD
Other Expenses
421k USD
Net Income
-14.4m USD
Fundamental Scores

PALI Profitability Score
Profitability Due Diligence

Palisade Bio Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Declining ROE
18/100
Profitability
Score

Palisade Bio Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

PALI Solvency Score
Solvency Due Diligence

Palisade Bio Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
71/100
Solvency
Score

Palisade Bio Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PALI Price Targets Summary
Palisade Bio Inc

Wall Street analysts forecast PALI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PALI is 11.9 USD with a low forecast of 6.06 USD and a high forecast of 22.05 USD.

Lowest
Price Target
6.06 USD
175% Upside
Average
Price Target
11.9 USD
441% Upside
Highest
Price Target
22.05 USD
902% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Palisade Bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PALI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PALI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PALI stock?

The intrinsic value of one PALI stock under the Base Case scenario is 0.08 USD.

Is PALI stock undervalued or overvalued?

Compared to the current market price of 2.2 USD, Palisade Bio Inc is Overvalued by 96%.

Back to Top